Decision Diagnostics Corp. DECN
OTC PK
| 09/30/2021 | 03/31/2021 | ||||
|---|---|---|---|---|---|
| Revenue | -0.42% | -6.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.42% | -6.27% | |||
| Cost of Revenue | -5.06% | 14.40% | |||
| Gross Profit | 20.10% | -45.46% | |||
| SG&A Expenses | 36.86% | -30.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.33% | -16.02% | |||
| Operating Income | -41.49% | 25.23% | |||
| Income Before Tax | 88.28% | -26.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 88.28% | -26.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 88.28% | -26.51% | |||
| EBIT | -41.49% | 25.23% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 89.68% | 41.30% | |||
| Normalized Basic EPS | 89.69% | 48.48% | |||
| EPS Diluted | 89.68% | 41.30% | |||
| Normalized Diluted EPS | 89.69% | 48.48% | |||
| Average Basic Shares Outstanding | 17.42% | 115.35% | |||
| Average Diluted Shares Outstanding | 17.42% | 115.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||